These are the three areas Robyn Scherber, MD, MPH, Assistant Professor of Medicine at the University of Texas Health Science Center at San Antonio, believes Quality Initiatives should focus on to deliver optimized care for patients with MPNs.
The elements of the Quality Initiative described have not been validated or approved for securing accreditation or reimbursement, nor has the information been supported or endorsed by any entity for these purposes.
Watch John Winters, MD, Staff Physician at New England Cancer Specialists, provide a physician's perspective on the practical application of Quality Initiatives (QIs) for patients with MPNs. He discusses the importance of regular symptom assessment and how you can involve your patients in tracking symptoms, and the role EMR records play in implementing a QI.
According to Michael Reff, RPh, MBA, Founder and Executive Director of the National Community Oncology Dispensing Association (NCODA), practices and pharmacists need to learn about rare cancers so they are better prepared to provide quality patient care. Watch as he discusses the importance of Quality Initiatives for patients with myeloproliferative neoplasms (MPNs).
Watch Kellie Mozingo, Executive Director, Vita Medical Associates P.C., explain why Quality Initiatives (QIs) for patients with MPNs are important to practices. She also shares how a practice manager determines which QI to implement, how her practice uses their EHR to monitor and identify patients that may require a different management approach and offers tips for successful MPN QIs.